Altesa BioSciences
Clinical-stage developer of oral antiviral medicines for people with chronic lung disease.
$75MSeries B
Role not disclosedAP
Atlantic Partners
Activity from announced rounds
Activity in this selectionnomura-real-estate-development-co-f095adde
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $75M 1 disclosed · full round size, not this investor’s share